Aberdeen, Scotland – EnteroBiotix, a privately held Scottish biotechnology company focused on using the body’s own microorganisms to prevent and treat disease, today announced that the Company’s CEO, James McIlroy, was awarded the title of ‘Young Pioneer of the Year’ at the inaugural Herald Scotland business awards.
The event, held at Glasgow Science Centre, recognised and rewarded innovation and sustainability at an international level, across all business sectors. The awards attracted entries from across the UK, from Aberdeen to London, as well as from the European mainland. It celebrated cross-sectoral innovators pioneering new ideas and products, particularly those helping to deliver a sustainable future and advance the United Nations Sustainable Development Goals.
Roy Gardner, executive director at City of Glasgow College, said: “Our congratulations go to a well-deserved winner whose ground-breaking project is helping to address and bridge the gender gap in STEM.”
For further information, please see the official article on the Herald website.
EnteroBiotix is a patient-centred biotechnology company developing novel medicinal products for use in infections or diseases associated with imbalances of bacteria in the human gut. The Company has established, staffed and integrated an ISO-accredited controlled donation facility and a fully equipped state-of-the-art manufacturing facility to manage collection, processing and formulation of medicinal products derived from healthy human donations. Headquartered in Aberdeen, EnteroBiotix has raised £700,000 in equity investment and non-dilutive funding with a dedicated core team of seven supported an Independent Scientific and Medical Advisory Board.
For further information, please contact:
James McIlroy, CEO